<DOC>
	<DOCNO>NCT02869750</DOCNO>
	<brief_summary>To evaluate possible clinical effect adipokines , ( ghrelin , resistin adiponectin ) , obese non-obese patient polycystic ovary syndrome ( PCOS ) .</brief_summary>
	<brief_title>Evaluation Adipokines Obese Non-obese Egyptian Women With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Seventy select PCOS patient recruit study , divide two group base body mass index ( BMI ) : 35 obese ( BMIâ‰¥ 25 kg/m2 , group A ) , 35 non-obese ( BMI &lt; 25 kg/m2 , group B ) . In addition , 35 healthy non-obese woman ( BMI &lt; 25 kg/m2 ) bw enrol control ( group C ) . Serum level FSH ( follicle stimulate hormone ) , LH ( luteinizing hormone ) , T ( testosterone ) , glucose , insulin , adiponectin , resistin resistin bw detect , compare difference among three group</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>Females PCOS child bear age present reproductive endocrinology clinic Ain Shams University Maternity Hospital Known androgen secrete tumor . PCO ovarian stimulation medication PCO medical illness .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>